Delivery Order SPE2DB22D3016-SPE2DB24FAZP7
Award Date
6/27/24
Potential Completion Date
6/28/24
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4566102755 - Methylergonovine 0.2 mg/ml vials. The $1,662.94 firm fixed-price delivery order contract does not have a set-aside designation and has an ultimate completion date of October 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,196.66 Firm Fixed Price Delivery Order contract is for the supply of 4567616841 - Methylergonovine 0.2 mg/ml Vials. The award is not associated with a set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Methylergonovine 0.2 mg/ml vials. The contract, valued at $5,983.20, is a Firm Fixed Price Delivery Order with an ultimate completion date of August 12, 2024. There was no set-aside designation for this award. Amerisourcebergen, through its Corporate Office division, has been awarded various federal contracts and Indefinite...
This federal contract award is for the delivery of 4,566,265 units of Methylergonovine 0.2 mg/ml vials, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The $1,242.55 firm-fixed-price delivery order contract has an ultimate completion date of October 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor and there is no set-aside designation. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
This federal contract award, valued at $1,794.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a delivery order contract for the supply of 4565019375 - Methylergonovine 0.2 mg/ml VLML, a pharmaceutical product, with a completion date of June 28, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565749596 - Methylergonovine 0.2 mg/ml vials. The contract is a Delivery Order with a Firm Fixed Price of $2,127.78 and an Ultimate Completion Date of September 11, 2024. The contract is not a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and there is no mention of any subcontractors. The contract is part of a larger...
This federal contract award, valued at $1,682.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,206,972 units of Methylergonovine 0.2 mg tablets by October 28, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,138.84 firm fixed-price delivery order is for the supply of 4563348085 METHYLERGONOVINE 0.2 MG/ML VLML, with a performance period through January 18, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
The federal contract award is for the delivery of the pharmaceutical product Methylergonovine 0.2 mg/ml, valued at $2,874.65. The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop...
This federal contract award, identified as SPE2DB22D3102|SPE2DB24FL2QL, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $1,995.36, is for the delivery of the medication methylergonovine 0.2 mg tablets in 12-count packages. This is a firm fixed-price delivery order contract with an ultimate completion date of August 22, 2024. The contract does not have a...